Prussian Blue Nanozyme Normalizes Microenvironment to Delay Osteoporosis (Adv. Healthcare Mater. 19/2022)

Advanced Healthcare Materials(2022)

引用 0|浏览2
暂无评分
摘要
Prussian Blue Nanoenzymes In article 2200787 by Rongxin He, Wei Gao, Xiaojun Cai and co-workers, hollow Prussian blue nanozymes (HPBZs) significantly normalize the osteoporosis microenvironment, thereby inhibiting osteoclast formation and osteoclast resorption for treatment of osteoporosis, possibly owing to the suppression of the mitogen-activated protein kinase and nuclear factor κB signaling pathways.
更多
查看译文
关键词
prussian blue nanozyme,delay osteoporosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要